App for cancer patients: MySunrise offers personalised support and resources during NHS treatment.
Condition Areas:
Cancer
Utilities and Administration
Clinical Features:
Information
General Features:
Data CaptureInformation ProvisionData SharingOnline ConsultationService Signposting
MySunrise
MySunrise is a free, award-winning app supporting adult patients through their cancer treatment at NHS Hospitals. This indispensable tool offers personalised guidance and up-to-date information, ensuring patients and their families receive specialised support every step of the way. With features like seamless video consultations, contact with healthcare teams, and tailored information specific to each NHS Hospital cancer centre, MySunrise transforms the cancer treatment journey. Accessible on iOS and Android, MySunrise ensures a hassle-free, personalised experience.
MySunrise is an award-winning free cancer companion app designed specifically to support patients throughout their cancer treatment at NHS Hospitals. The v3.0 MySunrise App is an indispensable tool for all patients and their families as they embark on their cancer treatment journey.
MySunrise offers a comprehensive, up-to-date information and reference tool that guides and supports patients through their entire cancer treatment pathway. The app facilitates effective communication between patients and their healthcare teams, ensuring timely contact and support for acute oncology helplines, virtual pre-assessments, pre-habilitation, holistic needs, and follow-up care after treatment.
One of the standout features of MySunrise is its ability to seamlessly connect patients to video consultations, enhancing the convenience and accessibility of care. The app is packed with a wide array of informational videos, relevant links, cancer resources, support groups, and contact information, all tailored specifically to the NHS Hospital cancer centre the patient is attending.
Specifically designed for adult patients undergoing cancer treatment, the MySunrise app falls within the Cancer, Utilities/Administration, and Information categories. By providing a personalised experience, MySunrise ensures that each patient receives specialised information pertinent to their own treatment centre.
Patients can access MySunrise via the Apple App Store or the Google Play Store, making it easily accessible on both iOS and Android devices. The streamlined interface allows for straightforward navigation and effortless utilisation of the features, ensuring a hassle-free experience for users.
MySunrise is not just a companion; it is a vital resource that empowers patients with the information and tools they need to navigate their cancer treatment with confidence. With tailored content specific to individual NHS Hospitals, MySunrise ensures that patients receive the most relevant and personalised support possible. By harnessing the power of technology, MySunrise is transforming the way patients experience cancer treatment, making it a must-have for anyone beginning their journey.
With MySunrise, patients can rest assured that they have a reliable and comprehensive support system right at their fingertips, aiding them every step of the way through their cancer treatment.
MySunrise Features
Data Collection, Sharing and Security
This app collects personal and sensitive data and provides details on purposes for data collection and usage, as well as data protection measures. Users can control some automatic data sharing through in-app preferences, but some data is shared automatically without an opt-out option, aside from accepting the privacy policy and terms. The app explains user rights related to data and ensures secure data storage and transfer.
Product information is subject to change and may have changed since this information was published. For inaccuracies, contact [email protected]
MySunrise Rating and Reviews
MySunrise Review
MySunrise Reviews will appear here when published.
MySunrise Review
MySunrise Reviews will appear here when published.
MySunrise Review
MySunrise Reviews will appear here when published.